Cancer
World’s largest clinical trial of aspirin in cancer launches in UK
October 22, 2015Research and Development CRUK, Cancer, Cancer Research UK, aspirin, clinical trial, phase III
The world’s largest ever clinical trial has been launched across the UK today, to discover whether taking aspirin every day …
Novartis acquires Admune Therapeutics
October 21, 2015Research and Development Admune Therapeutics, Cancer, Novartis, Palobiofarma, immunotherapy
Novartis is broadening its portfolio of cancer immunotherapies with the acquisition of Admune Therapeutics, and signing licensing agreements with Palobiofarma …
ImmunoCellular awarded $19.9 million grant for ICT-107 phase 3 trial for glioblastoma
September 25, 2015Research and Development California Institute for Regenerative Medicine, Cancer, ICT-107, brain cancer, glioblastoma
ImmunoCellular Therapeutics has been awarded a $19.9 million grant by California Institute for Regenerative Medicine (CIRM), California’s stem cell agency, …
Amgen joins M&A rush with deals for Dezima and Xencor
September 16, 2015Research and Development, Sales and Marketing Amgen, Cancer, Denzime, Xencor, cardiovascular disease, high cholesterol, inflammation
Amgen has struck deals that could potentially be worth $3.25 billion, to purchase the Dutch firm Dezima and kick-off a …
Cancers diagnosed earlier in England, but cases rise
September 16, 2015Cancer, Jeremy Hunt, Public Health England, cancer diagnosis, public health
The proportion of cancers diagnosed by GPs under the ‘two-week wait’ referral pathway rose, and late diagnoses fell, after the …
Counting the true cost of the Cancer Drugs Fund cuts
September 14, 2015Research and Development Cancer, Cancer Drugs Fund, NHS, clinical trials, cuts, oncology
Leading figures from the pharma industry and cancer charities reacted with dismay to the recent cuts to the Cancer Drugs …
Medimmune and Cancer Research UK launch new drug discovery lab
September 11, 2015Research and Development AstraZeneca, Cambridge, Cancer, Cancer Research UK, MedImmune, R&D, george freeman
MedImmune and the UK’s biggest cancer charity have opened a new laboratory for joint cancer research.Research at the laboratory, which …
Yabao Pharmaceutical and UniSA embark on joint venture
September 9, 2015Research and Development Cancer, Yabao Pharmaceutical
Yabao Pharmaceutical and the University of South Australia (UniSA) have joined together in a collaboration to develop new treatments for …
Celgene threatens to scale back UK clinical trial investment after CDF snub
September 4, 2015Research and Development, Sales and Marketing Cancer, Cancer Drugs Fund, Celgene, Revlimid, british nhs
One of the world’s leading pharma companies in oncology is considering whether to continue investing in clinical trials in the …
Companies braced for new round of cancer cuts
September 4, 2015Medical Communications, Sales and Marketing CDF, Cancer, Cancer Drugs Fund, NHS, NHS England, cuts
Several treatments that extend the lives of people with cancer are expected to be removed from the Cancer Drugs Fund …
Novartis blood cancer drug Farydak receives EU approval
September 4, 2015Sales and Marketing Cancer, European Commission, Farydak, Novartis, multiple myeloma, myeloma, panobinostat
The European Commission has approved Novartis’s Farydak, in combination with Velcade and dexamethasone, for the treatment of adult patients with …
How ‘deep reading’ of the scientific literature will benefit pharma
September 3, 2015Research and Development Big Data, Cancer, Data Mining, R&D, literature search, oncology
The US Defense Advanced Research Projects Agency (DARPA)’s $45 million ‘Big Mechanism’ initiative has an ambitious aim.It promises to “leapfrog …
Immatics and MD Anderson launch new company to develop ACR therapies
August 27, 2015Research and Development, Sales and Marketing Cancer, MD Anderson Cancer Center, immatics, keytruda
Immatics Biotechnologies and The University of Texas MD Anderson Cancer Center (MDACC) have together launched a new company focusing on …
AstraZeneca and Peregrine in immuno-oncology collaboration
August 24, 2015Research and Development AstraZeneca, Cancer, MEDI4736, Peregrine, Peregrine Pharmaceuticals, bavituximab, durvalumab, immunoncology, immunotherapy, oncology, tumours
AstraZeneca and Peregrine Pharmaceuticals will collaborate on a clinical trial to test two of the companies’ cancer treatments. The Phase …
Merck in immuno-oncology collaboration with major cancer research centre
August 14, 2015Research and Development Cancer, Merck, keytruda, oncology
Merck is teaming up with the University of Texas to evaluate Merck’s anti-PD-1 therapy, Keytruda, in combination with other treatmentsA team …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
